Tin tức & Cập nhật

Liver transplant candidates with NASH cirrhosis less likely to receive new organ

23 Oct 2023 bởi

Waitlisted registrants for liver transplantation (LT) who have nonalcoholic steatohepatitis (NASH) cirrhosis have a lower chance to receive a new organ and greater risk of waitlist mortality at 90 days and 1 year than patients with non-NASH cirrhosis, suggest the results of a Singapore study.

Liver transplant candidates with NASH cirrhosis less likely to receive new organ

23 Oct 2023

Obeticholic acid shows therapeutic potential in LPAC syndrome

22 Oct 2023

The selective farnesoid-X receptor agonist obeticholic acid appears to improve symptoms of low phospholipid-associated cholelithiasis (LPAC) syndrome in patients who have inadequate response or intolerance to ursodeoxycholic acid, as shown in a small study.

Obeticholic acid shows therapeutic potential in LPAC syndrome

22 Oct 2023

Pegozafermin shows promise in NASH patients

13 Oct 2023

In the treatment of patients with nonalcoholic steatohepatitis (NASH), the glycoPEGylated FGF21 analogue pegozafermin appears to confer beneficial effects on hepatic and metabolic parameters while being well tolerated, according to the results of a phase 1b/2a clinical trial.

Pegozafermin shows promise in NASH patients

13 Oct 2023

5-MTHF improves portal pressure reduction with propranolol in cirrhosis patients

04 Oct 2023

Treatment with 5-methyltetrahydrofolate (5-MTHF) significantly enhances the effect of propranolol in reducing hepatic venous pressure gradient (HVPG) in patients with cirrhosis and portal hypertension, a recent study has shown.

5-MTHF improves portal pressure reduction with propranolol in cirrhosis patients

04 Oct 2023

Hepatocyte-derived biomarkers predict liver-related events in alcohol-related cirrhosis

04 Oct 2023

The combination of hepatocyte-derived biomarkers and FibroTest or model for end-stage liver disease (MELD) scores can help identify patients with Child-Pugh class A alcohol-related cirrhosis who are prone to liver-related events at 2 years, reports a study.

Hepatocyte-derived biomarkers predict liver-related events in alcohol-related cirrhosis

04 Oct 2023

Efinopegdutide beats semaglutide at reducing liver fat in NAFLD patients

03 Oct 2023 bởi

Treatment with the glucagon-like peptide-1 (GLP-1)/glucagon receptor co-agonist efinopegdutide results in a greater decrease in liver fat content (LFC) relative to the GLP-1 receptor agonist semaglutide in patients with nonalcoholic fatty liver disease (NAFLD), results of a phase IIa trial have shown.

Efinopegdutide beats semaglutide at reducing liver fat in NAFLD patients

03 Oct 2023

Response to nucleos(t)ide analogues for hepatitis B higher among men vs women

25 Sep 2023

Treatment outcomes with nucleos(t)ide analogues for hepatitis B patients appear to differ by sex, such that men are more likely to have biochemical response and achieve clinical remission than women, a study has shown.

Response to nucleos(t)ide analogues for hepatitis B higher among men vs women

25 Sep 2023

Simvastatin phối hợp thuốc chẹn beta cải thiện khả năng sống sót ở bệnh nhân xơ gan kèm xuất huyết do giãn tĩnh mạch

23 Sep 2023 bởi

Theo một nghiên cứu được trình bày tại EASL 2023, việc phối hợp simvastatin với thuốc chẹn beta không chọn lọc giúp cải thiện khả năng sống sót ở những bệnh nhân xơ gan bị xuất huyết do giãn tĩnh mạch.

Simvastatin phối hợp thuốc chẹn beta cải thiện khả năng sống sót ở bệnh nhân xơ gan kèm xuất huyết do giãn tĩnh mạch

23 Sep 2023

Antidepressant use among HCC patients linked to lower risk of death

22 Sep 2023

For patients with hepatocellular carcinoma (HCC), the use of antidepressants after diagnosis may signal increased overall and cancer-specific survival, according to a study.

Antidepressant use among HCC patients linked to lower risk of death

22 Sep 2023

Mycophenolate mofetil giúp thuyên giảm bệnh tốt hơn azathioprine trong bệnh viêm gan tự miễn

21 Sep 2023 bởi

Theo kết quả của nghiên cứu CAMARO, trong số những bệnh nhân bị viêm gan tự miễn chưa qua điều trị, số bệnh nhân thuyên giảm bệnh ở nhóm dùng mycophenolate mofetil nhiều hơn nhóm azathioprine.

Mycophenolate mofetil giúp thuyên giảm bệnh tốt hơn azathioprine trong bệnh viêm gan tự miễn

21 Sep 2023

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Liver transplant candidates with NASH cirrhosis less likely to receive new organ

Liver transplant candidates with NASH cirrhosis less likely to receive new organ

Obeticholic acid shows therapeutic potential in LPAC syndrome

Obeticholic acid shows therapeutic potential in LPAC syndrome

Pegozafermin shows promise in NASH patients

Pegozafermin shows promise in NASH patients

5-MTHF improves portal pressure reduction with propranolol in cirrhosis patients

5-MTHF improves portal pressure reduction with propranolol in cirrhosis patients

Hepatocyte-derived biomarkers predict liver-related events in alcohol-related cirrhosis

Hepatocyte-derived biomarkers predict liver-related events in alcohol-related cirrhosis

Efinopegdutide beats semaglutide at reducing liver fat in NAFLD patients

Efinopegdutide beats semaglutide at reducing liver fat in NAFLD patients

Response to nucleos(t)ide analogues for hepatitis B higher among men vs women

Response to nucleos(t)ide analogues for hepatitis B higher among men vs women

Simvastatin phối hợp thuốc chẹn beta cải thiện khả năng sống sót ở bệnh nhân xơ gan kèm xuất huyết do giãn tĩnh mạch

Simvastatin phối hợp thuốc chẹn beta cải thiện khả năng sống sót ở bệnh nhân xơ gan kèm xuất huyết do giãn tĩnh mạch

Antidepressant use among HCC patients linked to lower risk of death

Antidepressant use among HCC patients linked to lower risk of death

Mycophenolate mofetil giúp thuyên giảm bệnh tốt hơn azathioprine trong bệnh viêm gan tự miễn

Mycophenolate mofetil giúp thuyên giảm bệnh tốt hơn azathioprine trong bệnh viêm gan tự miễn